- Home
- ATAI vs GHI Comparison
ATAI vs GHI Comparison
Compare ATAI & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- GHI
- Stock Information
- Founded
- ATAI 2018
- GHI 1998
- Country
- ATAI Germany
- GHI United States
- Employees
- ATAI N/A
- GHI N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- GHI Finance: Consumer Services
- Sector
- ATAI Health Care
- GHI Finance
- Exchange
- ATAI Nasdaq
- GHI Nasdaq
- Market Cap
- ATAI 282.6M
- GHI 264.1M
- IPO Year
- ATAI 2021
- GHI N/A
- Fundamental
- Price
- ATAI $1.41
- GHI $11.43
- Analyst Decision
- ATAI Strong Buy
- GHI Strong Buy
- Analyst Count
- ATAI 3
- GHI 4
- Target Price
- ATAI $10.50
- GHI $16.00
- AVG Volume (30 Days)
- ATAI 1.4M
- GHI 40.7K
- Earning Date
- ATAI 05-19-2025
- GHI 05-07-2025
- Dividend Yield
- ATAI N/A
- GHI 12.90%
- EPS Growth
- ATAI N/A
- GHI N/A
- EPS
- ATAI N/A
- GHI 0.45
- Revenue
- ATAI $308,000.00
- GHI $34,065,322.00
- Revenue This Year
- ATAI $65.58
- GHI $232.85
- Revenue Next Year
- ATAI N/A
- GHI N/A
- P/E Ratio
- ATAI N/A
- GHI $25.63
- Revenue Growth
- ATAI N/A
- GHI N/A
- 52 Week Low
- ATAI $1.03
- GHI $10.12
- 52 Week High
- ATAI $2.57
- GHI $15.80
- Technical
- Relative Strength Index (RSI)
- ATAI 44.57
- GHI 44.56
- Support Level
- ATAI $1.36
- GHI $11.27
- Resistance Level
- ATAI $1.54
- GHI $12.70
- Average True Range (ATR)
- ATAI 0.09
- GHI 0.45
- MACD
- ATAI -0.00
- GHI 0.01
- Stochastic Oscillator
- ATAI 0.00
- GHI 16.98
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.